Endoscopic retrograde cholangiopancreatography (ERCP) approach for patients with Roux-en-Y gastric bypass: a comparative study between four ERCP techniques with proposed management algorithm

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2024
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
GHAZI, Rabih
RAZZAK, Farah Abdul
KERBAGE, Anthony
STORM, Andrew C.
VARGAS, Eric J.
BOFILL-GARCIA, Aliana
CHANDRASEKHARA, Vinay
LAW, Ryan J.
MARTIN, John A.
Citação
SURGERY FOR OBESITY AND RELATED DISEASES, v.20, n.1, p.53-61, 2024
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Endoscopic retrograde cholangiopancreatography (ERCP) is technically challenging in patients with Roux-en-Y gastric bypass (RYGB) due to altered anatomy.Objective: To compare the procedural and clinical outcomes of 4 different ERCP techniques in RYGB patients.Setting: Academic tertiary referral center in the United States. Methods: A retrospective cohort study including patients with RYGB anatomy who underwent an ERCP between January 2015 and September 2020. We compared procedural success and adverse events (AEs) rates of balloon-assisted enteroscopy (BAE), gastrostomy-assisted ERCP (GAE), endoscopic ultrasound (EUS)-directed transgastric ERCP (EDGE), and rendezvous guidewire-assisted ERCP (RGA).Results: Seventy-eight RYGB patients underwent a total of 132 ERCPs. The mean age was 60 +/- 11.8 years, with female predominance (85.7%). The ERCP procedures performed were BAE (n = 64; 48.5%), GAE (n = 18; 13.7%), EDGE (n = 25; 18.9%), and RGA (n = 25; 18.9%), with overall procedure success rates of 64.1%, 100%, 89.5%, and 91.7%, respectively. All approaches were superior to BAE (GAE versus BAE, P =.003; EDGE versus BAE, P =.034; RGA versus BAE, P =.011). The overall AE rates were 10.9%, 11.1%, 15.8 %, and 25.0%, respectively. There was no statistical difference in AEs. There were also no differences in bleeding, post-ERCP pancreatitis, and perforation rates between the 4 approaches.Conclusion: Procedure success was similar between GAE, RGA, and EDGE, but superior to BAE. AE rates were similar between approaches. (Surg Obes Relat Dis 2024;20:53-61.) (c) 2024 American Society for Metabolic and Bariatric Surgery.
Palavras-chave
ERCP, Roux-en-Y gastric bypass, Choledocholithiasis, Endoscopic ultrasound, Bariatric surgery
Referências
  1. Abbas AM, 2018, GASTROINTEST ENDOSC, V87, P1031, DOI 10.1016/j.gie.2017.10.044
  2. Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779
  3. Blom-Hogestol IK, 2018, SURG OBES RELAT DIS, V14, P1544, DOI 10.1016/j.soard.2018.06.004
  4. Bowman E, 2016, SURG ENDOSC, V30, P4647, DOI 10.1007/s00464-016-4746-8
  5. Bukhari M, 2018, GASTROINTEST ENDOSC, V88, P486, DOI 10.1016/j.gie.2018.04.2356
  6. Chiang AL, 2018, GASTROINTEST ENDOSC, V87, pAB70
  7. Choi EK, 2013, SURG ENDOSC, V27, P2894, DOI 10.1007/s00464-013-2850-6
  8. Clapp B, 2022, SURG OBES RELAT DIS, V18, P1134, DOI 10.1016/j.soard.2022.06.284
  9. Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2
  10. da Ponte-Neto AM, 2018, OBES SURG, V28, P4064, DOI 10.1007/s11695-018-3507-2
  11. Dhindsa BS, 2020, ENDOSC INT OPEN, V8, pE163, DOI 10.1055/a-1067-4411
  12. Hajibandeh S, 2019, WORLD J SURG, V43, P1935, DOI 10.1007/s00268-019-05005-y
  13. Ishii K, 2016, GASTROINTEST ENDOSC, V83, P377, DOI 10.1016/j.gie.2015.06.020
  14. Kashani A, 2018, ENDOSC INT OPEN, V6, pE885, DOI 10.1055/a-0599-6059
  15. Kedia P, 2019, J CLIN GASTROENTEROL, V53, P304, DOI 10.1097/MCG.0000000000001037
  16. Khan MA, 2018, GASTROINTEST ENDOSC, V87, pAB452
  17. Khara Harshit S, 2021, Curr Gastroenterol Rep, V23, P10, DOI 10.1007/s11894-021-00808-3
  18. Krafft MR, 2019, ENDOSC INT OPEN, V7, pE1231, DOI 10.1055/a-0915-2192
  19. Li ZQ, 2020, J MINIM ACCESS SURG, V16, P206, DOI 10.4103/jmas.JMAS_146_18
  20. Lopes TL, 2009, GASTROINTEST ENDOSC, V70, P1254, DOI 10.1016/j.gie.2009.07.035
  21. Moreels TG, 2014, WORLD J GASTRO ENDOS, V6, P345, DOI 10.4253/wjge.v6.i8.345
  22. Neumann H, 2009, DIGESTION, V80, P52, DOI 10.1159/000216351
  23. Paranandi B, 2016, FRONTLINE GASTROENTE, V7, P54, DOI 10.1136/flgastro-2015-100556
  24. Runge TM, 2021, ENDOSCOPY, V53, P611, DOI 10.1055/a-1254-3942
  25. Saleem A, 2010, ENDOSCOPY, V42, P656, DOI 10.1055/s-0030-1255557
  26. Saleem A, 2012, J GASTROINTEST SURG, V16, P203, DOI 10.1007/s11605-011-1760-y
  27. Sawas T, 2020, SURG ENDOSC, V34, P806, DOI 10.1007/s00464-019-06832-9
  28. Schreiner MA, 2012, GASTROINTEST ENDOSC, V75, P748, DOI 10.1016/j.gie.2011.11.019
  29. Shinn B, 2021, GASTROINTEST ENDOSC, V94, P727, DOI 10.1016/j.gie.2021.04.022
  30. Snauwaert C, 2015, ENDOSC INT OPEN, V3, pE458, DOI 10.1055/s-0034-1392108
  31. Wang TJ, 2021, SURG ENDOSC, V35, P4469, DOI 10.1007/s00464-020-07952-3
  32. Yancey KH, 2018, J OBES, V2018, DOI 10.1155/2018/8275965